Cancer Follow-up
  1. During the surge leading up to and at the apogee of the COVID-19 incidence curve:
  2. Routine follow-ups in asymptomatic patients should be delayed, including routine follow-up imaging.
  3. Radiologic surveillance for patients who are cancer-free but are at risk for developing a cancer in the future should be delayed unless symptoms or signs are concerning.
  4. Follow-up later in the COVID-19 pandemic when routine office visits have resumed:
  5. Resume routine follow-ups in asymptomatic patients, including routine follow-up imaging
  6. Since a third of asymptomatic COVID-19 patients have characteristic chest CT findings, all patients that undergo CT of the chest or total body PET/CT as part of their routine follow-imaging for their cancer and who have radiographic evidence suggesting viral infection should undergo SAR-CoV-2 testing.22